Retargeting of adenoviral vectors to neurons using the HC fragment of tetanus toxin

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Gene Therapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3301270PMID 11021597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-viral neuronal gene delivery mediated by the HC fragment of tetanus toxin.

  2001cited by this paper
• In utero gene therapy: The case for

  1999cited by this paper
• Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoter

  1999cited by this paper
• Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector.

  1999cited by this paper
• Characterization of an Adenovirus Vector Containing a Heterologous Peptide Epitope in the HI Loop of the Fiber Knob

  1998cited by this paper
• High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity.

  1998cited by this paper
• High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels of α 1-Antitrypsin with Negligible Toxicity

  1998cited by this paper
• High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5

  1998cited by this paper
• Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors

  1997cited by this paper
• Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system.

  1997cited by this paper
• Use of a novel cross-linking method to modify adenovirus tropism

  1997cited by this paper
• Development of an HSV-based vector for the treatment of Parkinson's disease.

  1997cited by this paper
• Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor.

  1997cited by this paper
• Delivery of recombinant tetanus-superoxide dismutase proteins to central nervous system neurons by retrograde axonal transport.

  1997cited by this paper
• Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins

  1997cited by this paper
• Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

  1996cited by this paper
• Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli

  1996cited by this paper
• Targeted gene delivery by tropism-modified adenoviral vectors

  1996cited by this paper
• Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies

  1996cited by this paper
• Gene transfer to neurons using herpes simplex virus-based vectors.

  1996cited by this paper
• The challenge of fetal gene therapy

  1995cited by this paper
• Neurospecific binding, internalization, and retrograde axonal transport.

  1995cited by this paper
• CuZn Superoxide Dismutase (SOD-1):Tetanus Toxin Fragment C Hybrid Protein for Targeted Delivery of SOD-1 to Neuronal Cells (*)

  1995cited by this paper
• Characterization of recombinant tetanus toxin derivatives suitable for vaccine development

  1995cited by this paper
• CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses.

  1995cited by this paper
• Characterization of the receptor-binding domain of tetanus toxin.

  1993cited by this paper
• Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin.

  1992cited by this paper
• Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin

  1992cited by this paper
• Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA.

  1991cited by this paper
• Enhanced CNS uptake of systemically administered proteins through conjugation with tetanus C-fragment.

  1990cited by this paper
• Retrograde transneuronal transfer of the C-fragment of tetanus toxin.

  1987cited by this paper
• Transsynaptic retrograde transport of fragment C of tetanus toxin demonstrated by immunohistochemical localization.

  1986cited by this paper
• Selective trans-synaptic migration of tetanus toxin after retrograde axonal transport in peripheral sympathetic nerves: a comparison with nerve growth factor.

  1977cited by this paper
• Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

  1977cited by this paper
• Tetanus toxin: direct evidence for retrograde intraaxonal transport.

  1975cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper

• Uptake and transport of clostridial neurotoxins

  2015cites this paper
• Bispecific Antibodies and Gene Therapy

  2011cites this paper
• Towards New Uses of Botulinum Toxin as a Novel Therapeutic Tool

  2011cites this paper
• pUNISHER: a high-level expression cassette for use with recombinant viral vectors for rapid and long term in vivo neuronal expression in the CNS.

  2011cites this paper
• Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons

  2011cites this paper
• Chapter 34 – Tetanus Toxin

  2009cites this paper
• Designer adenoviruses for nanomedicine and nanodiagnostics.

  2009cites this paper
• Clostridium Neurotoxin Fragments as Potential Targeting Moieties for Liposomal Gene Delivery to the CNS

  2008cites this paper
• Engineered toxins: new therapeutics.

  2008cites this paper
• A MEANS FOR TARGETING THERAPEUTICS TO PERIPHERAL NERVOUS SYSTEM NEURONS WITH AXONAL DAMAGE

  2007cites this paper
• Gene therapy methods in bone and joint disorders

  2007cites this paper
• Nonviral Approaches for Neuronal Delivery of Nucleic Acids

  2007cites this paper
• CHAPTER 20 – Viral Vector Axonal Uptake and Retrograde Transport: Mechanisms and Applications

  2006cites this paper
• Gene‐based treatment of motor neuron diseases

  2006cites this paper
• CHAPTER 20 – Uptake and transport of Clostridium neurotoxins

  2006cites this paper
• Α genetic fusion construct between the tetanus toxin C fragment and the lysosomal acid hydrolase β‐glucuronidase expresses a bifunctional protein with enhanced secretion and neuronal uptake

  2005cites this paper
• Adenoviral interneuronal transportation after retrograde gene transfer in mice.

  2005cites this paper
• Utilisation du fragment C-terminal de la neurotoxine tétanique pour visualiser et analyser des connexions neuronales et pour le transfert d'une activité biologique associée

  2005influential citation
• Approaches to improving the kinetics of adenovirus-delivered genes and gene products.

  2005cites this paper
• How to keep injured CNS neurons viable--strategies for neuroprotection and gene transfer to retinal ganglion cells.

  2004cites this paper
• Axonal transport and neuronal transcytosis of trophic factors, tracers, and pathogens.

  2004cites this paper
• The Potential for Gene Therapy of Neurodegenerative Disorders

  2004cites this paper
• Axonal transport and neuronal transcytosis of trophic factors, tracers, and pathogens

  2004cites this paper
• Delivery Using Herpes Simplex Virus

  2004cites this paper
• Gentherapie in utero: Erfahrungen und Limitationen

  2002cites this paper
• New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entry.

  2002cites this paper
• Chapter 8 – Targeted Adenoviral Vectors I: Transductional Targeting

  2002cites this paper
• In vivo neuronal tracing with GFP-TTC gene delivery.

  2002cites this paper
• Targeted adenoviral vectors

  2002cites this paper
• Targeted adenoviral vectors.

  2002cites this paper
• Adeno-Associated Virus

  2002cites this paper
• Neuronal targeting of cardiotrophin-1 by coupling with tetanus toxin C fragment.

  2001cites this paper
• Viral-based gene transfer to the mammalian CNS for functional genomic studies.

  2001cites this paper
• Gene therapy for central nervous system repair.

  2001cites this paper